UnitedHealth Group Incorporated UNH
376.59
1.58
0.42%
as of 25 Sep
- Market cap
- $336.8B
- P/E
- 24.2×
Follow UNH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
UnitedHealth Group Incorporated (UNH) EBITDA
UnitedHealth Group Incorporated's EBITDA for fiscal 2025 was $23.3B, down 35.9% from $36.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $26.0B. Over the past ten years it has ranged from $12.7B (fiscal 2015) to $36.4B (fiscal 2024); the current reading is higher than 55% of that period. UnitedHealth Group Incorporated ranks 1st of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Annual
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $23.3B | (35.90%) |
| FY2024 | $36.4B | 0.15% |
| FY2023 | $36.3B | 14.12% |
| FY2022 | $31.8B | 17.59% |
| FY2021 | $27.1B | 7.02% |
| FY2020 | $25.3B | 12.90% |
| FY2019 | $22.4B | 13.32% |
| FY2018 | $19.8B | 13.28% |
| FY2017 | $17.5B | 16.48% |
| FY2016 | $15.0B | 17.86% |
Quarterly
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $9.0B | (9.86%) |
| Mar 2026 | $10.0B | 569.27% |
| Dec 2025 | $1.5B | (72.35%) |
| Sep 2025 | $5.4B | (13.15%) |
| 42 more quarters | Free account |
Against its own ten years
Low $12.7B
High $36.4B
Ten-year median
$23.3B
Current reading's percentile
55
EBITDA against peers
| Company | EBITDA |
|---|---|
| UNH UnitedHealth Group Incorporated | $26.0B |
| CVS CVS Health Corporation compare | $18.5B |
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $8.8B |
| HUM Humana Inc. compare | $3.5B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $371.0M |
| CLOV Clover Health Investments, Corp. compare | −$18.2M |
| CNC Centene Corporation compare | −$4.4B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on UNH
- Revenue
- Net income
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement